SGLT-2 Drugs May Cut Renal Injury Risk in Hospital Setting Edited by Javed Choudhury Medscape UK May 07, 2026

https://www.medscape.com/viewarticle/sglt-2-drugs-may-cut-renal-injury-risk-hospital-setting-2026a1000eg4 Use of SGLT-2 inhibitor therapy at admission was associated with a 32% reduced risk for acute kidney injury (AKI) in hospitalised patients, and this benefit was maintained when therapy was continued during hospitalisation. Patients who received SGLT-2 inhibitor therapy at admission were also less likely to experience progression to severe stages of AKI.